David Arambilet
Overview
Explore the profile of David Arambilet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Hernandez V, Arambilet D, Guillen Y, Lobo-Jarne T, Maqueda M, Gekas C, et al.
EMBO Mol Med
. 2023 Jan;
15(2):e16554.
PMID: 36597789
Understanding the molecular mechanisms that contribute to the appearance of chemotherapy resistant cell populations is necessary to improve cancer treatment. We have now investigated the role of β-catenin/CTNNB1 in the...
2.
Bigas A, Guillen Y, Schoch L, Arambilet D
Bioessays
. 2019 Dec;
42(2):e1900099.
PMID: 31854474
β-Catenin/CTNNB1 is critical for leukemia initiation or the stem cell capacity of several hematological malignancies. This review focuses on a general evaluation of β-catenin function in normal T-cell development and...
3.
Bueno C, Calero-Nieto F, Wang X, Valdes-Mas R, Gutierrez-Aguera F, Roca-Ho H, et al.
Haematologica
. 2019 Jan;
104(6):1189-1201.
PMID: 30679325
The t(4;11)(q21;q23) translocation is associated with high-risk infant pro-B-cell acute lymphoblastic leukemia and arises prenatally during embryonic/fetal hematopoiesis. The developmental/pathogenic contribution of the t(4;11)-resulting (MA4) and (A4M) fusions remains unclear;...